2MO Final OS results and subgroup analysis of savolitinib in patients with MET exon 14 skipping mutations (METex14+) NSCLC

Shaoming Lu, Jian Fang, X. Li, Lei Cao, Jinting Zhou, Qianqian Guo, Zhide Liang, Y. Cheng, L. Jiang, Ning Yang, Ze‐Guang Han, Jiaojian Shi, Y. Chen, Haoqian Xu, H. Zhang, G. Chen, Rui Ma, Sanyuan Sun, Yong Fan, S. Weiguo